Cutaneous microvascular responses are improved after cholesterol-lowering in patients with peripheral vascular disease and hypercholesterolaemia.
Khan
F
F
University Department of Medicine, Ninewells Hospital and Medical School, Dundee, Scotland.
Litchfield
S J
SJ
Belch
J J
JJ
D000109:Acetylcholine / Q000494:pharmacology; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001783:Blood Flow Velocity / Q000187:drug effects; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use*; D005260:Female; D000077340:Fluvastatin; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D007211:Indoles / Q000627:therapeutic use*; D007866:Leg / Q000098:blood supply; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000503:physiopathology*; D008875:Middle Aged; D009599:Nitroprusside / Q000494:pharmacology; D016491:Peripheral Vascular Diseases / Q000150:complications / Q000503:physiopathology*; D012867:Skin / Q000098:blood supply*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D014280:Triglycerides; D009599:Nitroprusside; D000077340:Fluvastatin; D000109:Acetylcholine